|
MEDP | Medpace Holdings, Inc. |
|
|
MEDP | Medpace Holdings, Inc. |
| Services-Commercial Physical & Biological Research |
| Book value per $ invested | $ 0.02 |
| Leverage | 78.91% |
| Market Cap | $ 17.8B |
| PE | 36.30 |
| Dividend Yield | 0.00% |
| Profit | $ 490.0m |
| Margin | 17.66% |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.